Literature DB >> 9426230

Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1.

I Tamai1, H Yabuuchi, J Nezu, Y Sai, A Oku, M Shimane, A Tsuji.   

Abstract

cDNA for a novel proton/organic cation transporter, OCTN1, was cloned from human fetal liver and its transport activity was investigated. OCTN1 encodes a 551-amino acid protein with 11 transmembrane domains and one nucleotide binding site motif. It is strongly expressed in kidney, trachea, bone marrow and fetal liver and in several human cancer cell lines, but not in adult liver. When expressed in HEK293 cells, OCTN1 exhibited saturable and pH-dependent [3H]tetraethyl ammonium uptake with higher activity at neutral and alkaline pH than at acidic pH. Furthermore, treatment with metabolic inhibitors reduced the uptake, which is consistent with the presence of the nucleotide binding site sequence motif. Although its subcellular localization and detailed functional characteristics are not clear at present, OCTN1 appears to be a novel proton antiporter that functions for active secretion of cationic compounds across the renal epithelial brush-border membrane. It may play a role in the renal excretion of xenobiotics and their metabolites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426230     DOI: 10.1016/s0014-5793(97)01441-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  68 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Cytokine regulation of OCTN2 expression and activity in small and large intestine.

Authors:  Mikihiro Fujiya; Yuhei Inaba; Mark W Musch; Shien Hu; Yutaka Kohgo; Eugene B Chang
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

Review 4.  Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.

Authors:  Akira Tsuji
Journal:  NeuroRx       Date:  2005-01

Review 5.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

6.  The promise and perils of interpreting genetic associations in Crohn's disease.

Authors:  T T Trinh; J D Rioux
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

7.  A human transporter protein that mediates the final excretion step for toxic organic cations.

Authors:  Masato Otsuka; Takuya Matsumoto; Riyo Morimoto; Shigeo Arioka; Hiroshi Omote; Yoshinori Moriyama
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

Review 8.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

9.  Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters.

Authors:  Mitsunori Okabe; Gergely Szakács; Mark A Reimers; Toshihiro Suzuki; Matthew D Hall; Takaaki Abe; John N Weinstein; Michael M Gottesman
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

10.  Combination Metabolomics Approach for Identifying Endogenous Substrates of Carnitine/Organic Cation Transporter OCTN1.

Authors:  Yusuke Masuo; Yuri Ohba; Kohei Yamada; Aya Hasan Al-Shammari; Natsumi Seba; Noritaka Nakamichi; Takuo Ogihara; Munetaka Kunishima; Yukio Kato
Journal:  Pharm Res       Date:  2018-10-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.